Involvement of central TRPV1 receptors in pentylenetetrazole and amygdala-induced kindling in male rats

Neurological Sciences

Volumn 35, Issue 8, 2014, Pages 1235-1241

  Shirazi, Mohsen ^a   Izadi, Mahin ^b   Amin, Masoud ^a   Rezvani, Mohammad Ebrahim ^a,b   Roohbakhsh, Ali ^c   Shamsizadeh, Ali ^a,d  

^a RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Iran National Science Foundation   (Iran)

Author keywords

AMG 9810; Amygdala; Kindling; OLDA; Pentylenetetrazole; TRPV1

Indexed keywords

N (1,4 BENZODIOXAN 6 YL) 3 (4 TERT BUTYLPHENYL)ACRYLAMIDE; PENTETRAZOLE; VANILLOID RECEPTOR 1; 3-(4-T-BUTYLPHENYL)-N-(2,3-DIHYDROBENZO(B)(1,4)DIOXIN-6-YL)ACRYLAMIDE; ACRYLAMIDE DERIVATIVE; CONVULSANT AGENT; DOPAMINE; FUSED HETEROCYCLIC RINGS; N-OLEOYLDOPAMINE; NERVE PROTEIN; TRPV1 PROTEIN, RAT; VANILLOID RECEPTOR;

ADULT; AFTERDISCHARGE; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; CLONUS; CONTROLLED STUDY; DISEASE COURSE; KINDLING; LATENT PERIOD; MALE; NONHUMAN; PENTYLENETETRAZOLE-INDUCED SEIZURE; RAT; ADVERSE EFFECTS; AGONISTS; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECTS; ELECTRODE IMPLANT; ELECTROSTIMULATION; IC50; MICROINJECTION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREMEDICATION; RANDOMIZATION; SYMPTOM ASSESSMENT; WISTAR RAT;

ACRYLAMIDES; AMYGDALA; ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; CONVULSANTS; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; ELECTRODES, IMPLANTED; INHIBITORY CONCENTRATION 50; KINDLING, NEUROLOGIC; MALE; MICROINJECTIONS; NERVE TISSUE PROTEINS; PENTYLENETETRAZOLE; PREMEDICATION; RANDOM ALLOCATION; RATS; RATS, WISTAR; SYMPTOM ASSESSMENT; TRPV CATION CHANNELS;

EID: 84905091600     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-014-1689-5     Document Type: Article

References (24)

1. Stafstrom CE (2003) Epileptogenesis beyond the hippocampus. Epilepsy Curr 3:66-67
2. Steinlein OK (2008) Genetics and epilepsy. Dialogues Clin Neurosci 10:29-38
3. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D (1997) The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389:816-824 (Pubitemid 27462969)
4. Hwang SW, Cho H, Kwak J, Lee SY, Kang CJ, Jung J, Cho S, Min KH, Suh YG, Kim D, Oh U (2000) Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc Nat Acad Sci 97:6155-6160 (Pubitemid 30367539)
5. Holzer P (1988) Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 24:739-768
6. Toth A, Boczan J, Kedei N, Lizanecz E, Bagi Z, Papp Z, Edes I, Csiba L, Blumberg PM (2005) Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain. Brain Res Mol Brain Res 135:162-168 (Pubitemid 40602409)
7. Cristino L, de Petrocellis L, Pryce G, Baker D, Guglielmotti V, Di Marzo V (2006) Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain. Neuroscience 139:1405-1415
8. Li HB, Mao RR, Zhang JC, Yang Y, Cao J, Xu L (2008) Antistress effect of TRPV1 channel on synaptic plasticity and spatial memory. Biol Psychiatry 64:286-292
9. Fu M, Xie Z, Zuo H (2009) TRPV1: a potential target for antiepileptogenesis. Med Hypotheses 73:100-102
10. Manna SS, Umathe S (2012) Involvement of transient receptor potential vanilloid type 1 channels in the pro-convulsant effect of anandamide in pentylenetetrazole-induced seizures. Epilepsy Res 100:113-124
11. Löscher W (2011) Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs. Seizure 20(5):359-368
12. Kupferberg H (2001) Animal models used in the screening of antiepileptic drugs. Epilepsia 42:7-12
13. Pitcher MH, Price TJ, Entrena JM, Cervero F (2007) Spinal NKCC1 blockade inhibits TRPV1-dependent referred allodynia. Mol Pain 30:3-17
14. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates, 4th edn. Academic Press, San Diego
15. Bhaskaran MD, Smith BN (2010) Effects of TRPV1 activation on synaptic excitation in the dentate gyrus of a mouse model of temporal lobe epilepsy. Exp Neurol 223:529-536
16. Rezvani ME, Roohbakhsh A, Mosaddegh MH, Esmailidehaj M, Khaloobagheri F, Esmaeili H (2011) Anticonvulsant and depressant effects of aqueous extracts of Carum copticum seeds in male rats. Epilepsy Behav 22(2):220-225
17. Rowley NM, Madsen KK, Schousboe A, Steve White H (2012) Glutamate and GABA synthesis, release, transport and metabolism as targets for seizure control. Neurochem Int 61:546-558
18. Adams B, Sazgar M, Osehobo P, Van der Zee CE, Diamond J, Fahnestock M, Racine RJ (1997) Nerve growth factor accelerates seizure development, enhances mossy fiber sprouting, and attenuates seizure-induced decreases in neuronal density in the kindling model of epilepsy. J Neurosci 17:5288-5296
19. Suzukawa J, Omori K, Okugawa G, Fujiseki Y, Heizmann CW, Inagaki C (1999) Long-lasting c-fos and NGF mRNA expressions and loss of perikaryal parvalbumin immunoreactivity in the development of epileptogenesis after ethacrynic acid-induced seizure. Brain Res 834:89-102 (Pubitemid 29332013)
20. Lee TH, Lee JG, Yon JM, Oh KW, Baek IJ, Nahm SS, Lee BJ, Yun YW, Nam SY (2011) Capsaicin prevents kainic acid-induced epileptogenesis in mice. Neurochem Int 58:634-640
21. Chung M, Guler AD, Caterina MJ (2008) TRPV1 shows dynamic ionic selectivity during agonist stimulation. Nat Neurosci 11(5):555-564 (Pubitemid 351595196)
22. Sato M, Racine RJ, McIntyre DC (1990) Kindling: basic mechanisms and clinical validity. Electroencephal Clin Neurophysiol 76:459-472 (Pubitemid 20370128)
23. Kauer JA, Connors BW, Kim JA, Gibson HE (2010) Treatment and prophylaxis of epilepsy and febrile seizures. US Patent App 12/879,058
24. Gavva NR, Tamir R, Qu Y, Klionsky L, Zhang TJ, Immke D, Wang J, Zhu D, Vanderah TW, Porreca F, Doherty EM, Norman MH, Wild KD, Bannon AW, Louis JC, Treanor JJ (2005) AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1, 4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties. J Pharmacol Exp Ther 313:474-484 (Pubitemid 40411374)